Drugs News and Research

RSS

Few HIV-positive people receiving antiretrovirals in Mozambique despite no-cost treatment program

Few HIV-positive people in Mozambique are coming forward to receive no-cost antiretroviral drugs despite a government program that provides access to the medications, Mozambican Health Minister Ivo Garrido said recently at a news conference, Reuters reports.

11 Jun 2008

U.N. high level meeting on AIDS to review progress in fighting disease

World leaders are expected to review progress in the fight against HIV/AIDS worldwide during the United Nations 2008 High Level Meeting on AIDS, scheduled for Tuesday and Wednesday in New York, the Washington Post reports (Lynch, Washington Post, 6/10).

11 Jun 2008

Guardian examines rise of pregnancies among HIV-positive women in Malawi

London's Guardian on Saturday profiled Grace Mathanga, an HIV-positive pregnant woman living in Malawi whom the newspaper first profiled five years ago.

11 Jun 2008

Neglect of HIV/TB coinfection 'undermining' gains against HIV, U.N. officials say at conference

Failure to adequately address HIV/tuberculosis coinfection is "undermining" recent gains against HIV/AIDS, United Nations officials said at the first HIV/TB Global Leaders Forum at U.N. headquarters in New York, the New York Times reports.

11 Jun 2008

European research project to explore Alzheimer's diagnosis

VTT Technical Research Centre of Finland, GE Healthcare, a division of the General Electric Company (NYSE: GE) and a Consortium of leading research institutions across Europe announced the PredictAD project, a research collaboration aimed at developing new diagnostic procedures for patients with Alzheimer's disease.

10 Jun 2008

World leaders call for action to reduce TB deaths among HIV-positive people

For the first time ever, heads of governments, public health and business leaders, heads of UN agencies and activists came together at UN Headquarters today to confront a threat to global health that could undermine investments in life-saving drug treatment for people living with HIV.

10 Jun 2008

Cancer prevention: the natural way

Certain dietary-based substances may prevent some cancers from developing and research at the University of Leicester is looking at natural compounds which may lead to a cancer chemopreventive drug.

10 Jun 2008

Irritable bowel syndrome linked to chilli pepper pain receptor

People with irritable bowel syndrome have a higher than usual number of chilli pepper pain receptors, according to a new study published tomorrow (Wednesday 11 June).

10 Jun 2008

Panel discusses expanding health coverage to uninsured via 'early Medicare' program

At a panel discussion on Friday, lawmakers and health experts considered a Commonwealth Fund proposal that would provide health insurance to 44 million of the 48 million uninsured U.S. residents, CQ HealthBeat reports (Wyckoff, CQ HealthBeat, 6/6).

10 Jun 2008

CQ's Carey discusses Democratic, GOP Medicare proposals, VA mental health bill, health care IT measure

Mary Agnes Carey, associate editor of CQ HealthBeat, discusses Senate Democratic and Republican measures to halt a 10.6% reduction to Medicare physician fees; Senate legislation involving veterans' mental health; and a House bill that encourages greater adoption of electronic health records in this week's "Health on the Hill from kaisernetwork.org and CQ."

10 Jun 2008

IRIN/PlusNews examines issues surrounding HIV-positive teenagers in Burkina Faso

IRIN/PlusNews on Thursday examined issues surrounding HIV-positive teenagers in Burkina Faso, who are living longer because of antiretroviral treatment and are "expecting to become sexually active" and have children.

10 Jun 2008

Researchers block the transmission of malaria in animal tests

By disrupting the potassium channel of the malaria parasite, a team of researchers has been able to prevent the malaria parasites from forming in mosquitoes and has thereby broken the cycle of infection during recent animal tests.

10 Jun 2008

Calls for tougher rules on complementary medicines in Australia

Pressure from a consumer group has prompted the Australian Federal Government to consider the introduction of far more stringent disclosure rules regarding complementary medicines.

10 Jun 2008

Administration proposes additional funding for FDA for fiscal year (FY) 2009

HHS Secretary Leavitt today announced that the Administration is amending its budget request for fiscal year (FY) 2009 to include an additional $275 million for the U.S. Food and Drug Administration (FDA). He called on Congress to act quickly on this budget amendment and pending Administration legislative proposals to strengthen FDA.

9 Jun 2008

Mylan announces final FDA approval for Zaleplon capsules, generic version of Sonata

Mylan Inc. has announced that its subsidiary, Genpharm ULC, has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Zaleplon Capsules, 5 mg and 10 mg.

9 Jun 2008

Latest research suggests tight glucose control for diabetics

It has been found that keeping tight control of blood sugar levels in type 2 diabetics reduces the risk of kidney disease by 21 percent, and that weight gain, the use of multiple drug combinations and getting blood sugar too low, too quickly may all have been factors in causing early deaths.

9 Jun 2008

Scientists closer to solving epilepsy mystery

Scientists in the United States believe they are a step closer to understanding why some people suffer from epileptic fits.

9 Jun 2008

Nose stem cells used to treat Parkinson's

Scientists in Queensland, Australia have made a major breakthrough in research into Parkinson's disease.

9 Jun 2008

Louisiana's Charity Hospitals need $35 million to continue services at current levels

Louisiana's Charity Hospitals will have to begin cutting services this summer unless the state Legislature provides them with an additional $35 million, Louisiana State University officials told the state Senate Finance Committee on Monday, the New Orleans Times-Picayune reports.

8 Jun 2008

Boehringer, Gilead freeze antiretroviral prices for some U.S. agencies

Pharmaceutical companies Boehringer Ingelheim and Gilead Sciences are freezing the prices of their antiretroviral drugs for select agencies in the U.S., the AIDS Healthcare Foundation announced on Tuesday, Bloomberg reports.

8 Jun 2008